Mayo Clinic's Department of Laboratory Medicine and Pathology is one of the largest clinical laboratories in the world. It is composed of more than 3,200 people working in 40 specialty laboratories performing more than 20 million tests a year. The department receives specimens for testing from Mayo Clinic and Mayo Clinic Health System and is a reference laboratory for other clinics and hospitals both nationally and internationally.
The Division of Transfusion Medicine consists of a highly skilled team of medical professionals, including physicians, scientists, medical technologists, medical technicians, lab assistants, biologists, chemists, microbiologists, geneticists and other specialists, who work collaboratively.
The Division of Transfusion Medicine is responsible for the collection and testing of blood transfused to patients at Mayo Clinic Hospital — Rochester. The team also collects and processes hematopoietic stem cells for blood and bone marrow transplantation, as well as performs the testing necessary for organ transplantation. Transfusion medicine specialists, each with different interests and specialty areas, take an active part in your training.
Facilities and practice volume
The Division of Transfusion Medicine collects more than 40,000 units of blood from 17,000 local donors.
The Therapeutic Apheresis Treatment Unit at Mayo Clinic is one of the oldest in the United States, starting operation in January 1974. It performs therapeutic apheresis procedures to treat patients with neurological, renal and blood diseases. Approximately 3,000 therapeutic apheresis procedures are performed each year, including approximately 1,000 peripheral blood hematopoietic stem cell collections and 1,500 plasma exchanges.
More than 75,000 products are administered. The Division of Transfusion Medicine performs approximately 60,000 red cell compatibility tests and 71,000 ABO and Rh blood typings annually.
The laboratories of the Division of Transfusion Medicine are accredited by the AABB, the Foundation for the Accreditation of Cellular Therapy (FACT), the College of American Pathologists (CAP), and the American Society for Histocompatibility and Immunogenetics (ASHI).
|Michael E. Stevenson, M.D.
|Michelle (Taylor) Lux, D.O., and Tahir Mehmood, M.D.
|Peter Clifford, D.O., Ph.D.
|Hollie Reeves, D.O.
|Justin D. Kreuter, M.D.